Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection
Clinical trial NCT02713204 · COMPLETED
Trial details
- NCT number
- NCT02713204
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-31
- Primary completion
- 2017-10-03
- Enrollment
- 365
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.